Figure 3.
Figure 3. Development of EPCs from EpoR-HM mice is attenuated at a Ter119-positive, CD71high stage. (A) EPCs in marrow preparations from EpoR-HM and wt-EpoR mice were expanded in the presence of Epo at 0.1, 0.4, or 1.6 U/mL. At 42 hours of culture, Ter119 and CD71 expression levels were assayed. Indicated in representative flow profiles (as percents of total events) are frequencies of Ter119-positive CD71+ populations (H gate, Ter119-positive CD71high; L gate, Ter119-positive CD71low EPCs). (B) Ter119-positive CD71high and CD71low EPCs were isolated by FACS and stained as cytospin preparations. For each, representative sets of cells are shown (predominantly proerythroblasts and basophilic erythroblasts as CD71high EPCs and chromatophilic erythroblasts as CD71low EPCs) (original magnification, × 400). (C) Graphed are mean ratios (plus or minus standard deviation) of CD71low/CD71high Ter119-positive cells formed in the presence of Epo at 0.1, 0.4, or 1.6 U/mL for EpoR-HM versus wt-EpoR mice (n = 3 + n = 3 mice).

Development of EPCs from EpoR-HM mice is attenuated at a Ter119-positive, CD71high stage. (A) EPCs in marrow preparations from EpoR-HM and wt-EpoR mice were expanded in the presence of Epo at 0.1, 0.4, or 1.6 U/mL. At 42 hours of culture, Ter119 and CD71 expression levels were assayed. Indicated in representative flow profiles (as percents of total events) are frequencies of Ter119-positive CD71+ populations (H gate, Ter119-positive CD71high; L gate, Ter119-positive CD71low EPCs). (B) Ter119-positive CD71high and CD71low EPCs were isolated by FACS and stained as cytospin preparations. For each, representative sets of cells are shown (predominantly proerythroblasts and basophilic erythroblasts as CD71high EPCs and chromatophilic erythroblasts as CD71low EPCs) (original magnification, × 400). (C) Graphed are mean ratios (plus or minus standard deviation) of CD71low/CD71high Ter119-positive cells formed in the presence of Epo at 0.1, 0.4, or 1.6 U/mL for EpoR-HM versus wt-EpoR mice (n = 3 + n = 3 mice).

Close Modal

or Create an Account

Close Modal
Close Modal